Bauhinia variegata (Caesalpiniaceae) leaf extract: An effective treatment option in type I and type II diabetes

Biomedicine and Pharmacotherapy

Volumn 83, Issue , 2016, Pages 122-129

  Kulkarni, Yogesh A ^a   Garud, Mayuresh S ^a  

^a SVKM s Narsee Monjee Institute of Management Studies   (India)

Author keywords

HDL; High fat diet; Insulin; Pancreases; Streptozotocin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ANTIDIABETIC AGENT; ASPARTATE AMINOTRANSFERASE; BAUHINIA VARIEGATA EXTRACT; CHOLESTEROL; CREATININE; GLIPIZIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; PLANT MEDICINAL PRODUCT; STREPTOZOCIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AYURVEDA; BAUHINIA VARIEGATA; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COLORIMETRY; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES CONTROL; DRUG DETERMINATION; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LIMIT OF QUANTITATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREATIC TISSUE; PLANT LEAF; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; ANIMAL; BAUHINIA; CHEMISTRY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; GLUCOSE TOLERANCE TEST; LIPID DIET; METABOLISM; PANCREAS; PATHOLOGY;

ANIMALS; BAUHINIA; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; GLUCOSE TOLERANCE TEST; MALE; PANCREAS; PHYTOCHEMICALS; PLANT EXTRACTS; PLANT LEAVES; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN;

EID: 84975815208     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.06.025     Document Type: Article

References (39)

1. [1] Guariguata, L., Estimating the worldwide burden of type 1 diabetes. Diabetes Voice 56:2 (2011), 6–7.
2. [2] Arafa, R., Naringenin as an antidermatophyte flavonoid aglycone from Bouhinia variegata. Al-Azhar J. Microbiol., 2001, 17–23.
3. [3] El-Dondaity, S.E., Mahdy, M., El-Hamouly, M., Ammar, H., Chemical and/or biological studies of Bauhinia variegata L. and Cleome droserifolia (Forssk.) Del. growing in Egypt. Egpt. J. Biomed. Sci. 19 (2005), 181–203.
4. [4] Maheswara, M., Rao, Y.K., Siddaiah, V., Rao, C.V., Isolation of new chalcone from the leaves of Bauhinia variegata. Asian J. Chem. 18 (2005), 419–422.
5. [5] Rajkapoor, B., Jayakar, B., Anandan, R., Kavimani, S., Anti-ulcer effect of Bauhinia variegata Linn. in rats. J. Nat. Rem. 3 (2003), 215–217.
6. [6] Rajkapoor, B., Jayakar, B., Murugesh, N., Antitumour activity of Bauhinia variegata on dalton's ascitic lymphoma. J. Ethnopharmacol. 89 (2003), 107–109.
7. [7] Yadava, R.N., Reddy, V.M.S., Anti-Inflammatory activity of a novel flavonol glycoside from the Bauhinia variegata Linn. Nat. Prod. Res. 17 (2003), 165–169.
8. [8] Kumar, D., Parcha, V., Dhulia, I., Maithani, A., Effect and valuation of anti-hyperlipidemic activity of methanol extract of Bauhinia variegata Linn. leaves in triton WR-1339 (Tyloxapol) induced hyperlipidemic rats. J. Pharm. Res. 4:1 (2011), 58–60.
9. [9] Mishra, A., Kumar, S., Bhargava, A., Sharma, B., Pandey, A.K., Studies on in vitro antioxidant and antistaphylococcal activities of some important medicinal plants. Cell. Mol. Biol. 57:1 (2011), 16–25.
10. [10] Ali, M.S., Azhar, I., Amtul, Z., Antimicrobial screening of some Caesalpiniaceae. Fitoterapia 70 (1999), 299–302.
11. [11] Frankish, N., de Sousa, M.F., Mills, C., Sheridan, H., Enhancement of insulin release from the beta-cell line INS-1 by an ethanolic extract of Bauhinia variegata and its major constituent roseoside. Planta Med. 76:10 (2010), 995–997.
12. [12] Rashid, K.I., Detection of insulin-like protein and some active compounds in Bauhinia variegata Linn. leaf ethanolic extracts and the effect in reducing blood glucose levels in Mice. IOSR J. Pharm. 4:3 (2014), 1–5.
13. [13] Khot, P.R., Agrawal, S.L., Patole, A.M., Tundulwar, M.R., Tenpe, C.R., Rathod, S.S., Antidibetic and antioxidant effect of ethanolic extract of Bauhinia varigata leaves in streptozotocin induced diabetic rats. Inventi Rapid: Ethnopharmacol., 2012 Available at www.inventi.in/Article/pep/568/11.aspx, (accessed 14.12.13).
14. [14] Kulkarni, Y.A., Garud, M.S., Effect of Bauhinia variegata Linn. (Caesalpiniaceae) extract in streptozotocin induced type I diabetic rats. Orient. Pharm. Exp. Med. 15:3 (2015), 191–198.
15. [15] Kulkarni, Y.A., Panjabi, R., Patel, V., Tawade, A., Gokhale, A., Effect of Gmelina arborea Roxb in experimentally induced inflammation and nociception. J. Ayurveda Integr. Med., 4(3), 2013, 152.
16. [16] Singelton, V.R., Orthifer, R., Lamuela-Raventos, R.M., Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin–Ciocalteu reagent. Methods Enzymol. 299 (1999), 152–178.
17. [17] Kumar, S., Kumar, D., Manjusha Saroha, K., Singh, N., Vashishta, B., Antioxidant and free radical scavenging potential of Citrullus colocynthis (L.) Schrad. methanolic fruit extract. Acta Pharm. 58:2 (2008), 215–220.
18. [18] Kulkarni, Y.A., Veeranjaneyulu, A., Effects of Gmelina arborea extract on experimentally induced diabetes. Asian Pac. J. Trop. Med. 6 (2013), 602–608.
19. [19] Srinivasan, K., Viswanad, B., Asrat, L., Kaul, C.L., Ramarao, P., Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol. Res. 52:4 (2005), 313–320.
20. [20] Lenzen, S., The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 51 (2008), 216–226.
21. [21] Ledoux, S.P., Woodley, S.E., Patton, N.J., Wilson, G.L., Mechanisms of nitrosourea-induced beta-cell damage alterations in DNA. Diabetes, 1986, 872.
22. [22] Murata, M., Takahashi, A., Saito, I., Kawanishi, S., Sitespecific DNA methylation and apoptosis: induction by diabetogenic streptozotocin. Biochem. Pharmacol. 57 (1999), 881–887.
23. [23] Arunachalam, K., Parimelazhagan, T., Antidiabetic activity of Ficus amplissima Smith. bark extract in streptozotocin induced diabetic rats. J. Ethnopharmacol. 147 (2013), 302–310.
24. [24] Beck-Nielsen, H., Insulin resistance: organ manifestations and cellular mechanisms. Ugeskr. Laeger. 164 (2002), 2130–2135.
25. [25] Gold, A.H., The effect of diabetes and insulin on liver glycogen synthetase activation. J. Biol. Chem. 245 (1970), 903–905.
26. [26] Raju, J., Gupta, D., Rao, A.R., Yadava, P.K., Baquer, N.Z., Trigonella foenumgraecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reserving the altered glycolytic, gluconeogenic and lipogenic enzymes. Mol. Cell. Biochem. 224 (2001), 45–51.
27. [27] Reaven, G.M., Insulin resistance, hyperinsulinemia, hypertriglyceridemia and hypertension: parallels between human disease and rodent models. Diabetes Care 14 (1991), 195–202.
28. [28] Pushparaj, P.N., Low, H.K., Manikandan, J., Tan, B.K.H., Tan, C.H., Anti-diabetic effects of Cichorium intybus in streptozotocin-induced diabetic rats. J. Ethnopharmacol. 111 (2007), 430–434.
29. [29] Ananthan, R., Latha, M., Ramkumar, K., Pari, L., Baskar, C., Bai, V., Effect of Gymnema montanum leaves on serum and tissue lipids in alloxan diabetic rats. Exp. Diabetes Res. 4 (2003), 183–189.
30. [30] Tan, B.K.H., Tan, C.H., Pushparaj, P.N., Anti-diabetic activity of the semi-purified fractions of Averrhoa bilimbi in high fat diet fed streptozotocin-induced diabetic rats. Life Sci. 76 (2005), 2827–2839.
31. [31] Kasetti, R.B., Rajasekhar, M.D., Kondeti, V.K., Fatima, S.S., Kumar, E.G., Swapna, S., Ramesh, B., Rao, C.A., Antihyperglycemic and antihyperlipidemic activities of methanol:water (4:1) fraction isolated from aqueous extract of Syzygium alternifolium seeds in streptozotoc ininduced diabetic rats. Food Chem. Toxicol. 48 (2010), 1078–1084.
32. [32] Srinivasan, K., Patole, P.S., Kaul, C.L., Ramarao, P., Reversal of glucose intolerance by pioglitazone in high-fat diet fed rats. Methods Find Exp. Clin. Pharmacol. 26 (2004), 327–333.
33. [33] Storlien, L.H., James, D.E., Burleigh, K.M., Chisholm, D.J., Kraegen, E.W., Fat feeding causes widespread in-vivo insulin resistance, decreased energy expenditure and obesity in the rat. Am. J. Physiol. 251 (1986), E576–E583.
34. [34] Nicolle, E., Souard, F., Faure, P., Boumendjel, A., Flavonoids as promising lead compounds in type 2 diabetes mellitus: molecules of interest and structure-activity relationship. Curr. Med. Chem. 18:17 (2011), 2661–2672.
35. [35] Patel, M.B., Mishra, S.H., Hypoglycemic activity of C-glycosyl flavonoid from Enicostemma hyssopifolium. Pharm. Biol. 49 (2011), 383–391.
36. [36] Mohan, S., Nandhakumar, L., Role of various flavonoids: hypotheses on novel approach to treat diabetes. J. Med. Hypotheses Ideas 8:1 (2014), 1–6.
37. [37] Kobori, M., Masumoto, S., Akimoto, Y., Takahashi, Y., Dietary quercetin alleviates diabetic symptoms and reduces streptozotocin-induced disturbance of hepatic gene expression in mice. Mol. Nutr. Food Res. 53 (2009), 859–868.
38. [38] Prasath, G.S., Subramanian, S.P., Modulatory effects of fisetin a bioflavonoid, on hyperglycemia by attenuating the key enzymes of carbohydrate metabolism in hepatic and renal dtissues in streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 668 (2011), 492–496.
39. [39] Babua, P.V.A., Liub, D., Gilbertc, E.R., Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J. Nutr. Biochem. 24 (2013), 1777–1789.